M. Masoli

Most-cited papers

1. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

   2021The Lancet1,685 citations Open access

   Semantic Scholar

   Save

2. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Eugenia Mustafa Sadia Alfie Ashraf Sherif Mohamed Basir Al Abaleke Abbas Abbasi Abbott Abdelaziz Abdelbadiee , E. Abaleke, M. Abbas, Sadia Abbasi +496 more

   2021The Lancet289 citations Open access

   Semantic Scholar

   Save

3. Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: the COSMEX Study.

   S. Khurana, G. Brusselle, E. Bel, J. Fitzgerald +8 more

   2019Clinical Therapeutics153 citations Open access

   Semantic Scholar

   Save

4. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

   Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

   2021The Lancet141 citations Open access

   Semantic Scholar

   Save

5. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma

   M. Masoli, M. Weatherall, S. Holt, R. Beasley

   2005Thorax131 citations Open access

   Semantic Scholar

   Save

6. A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales

   M. Hyland, B. Whalley, Rupert C. Jones, M. Masoli

   2015Quality of Life Research115 citations Open access

   Semantic Scholar

   Save

7. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

   O. A. F. J. K. M. S. H. A. Abani Abbas Abbas Abbas Abbas Abbas Abbasi Abbass, O. Abani, A. Abbas, F. Abbas +496 more

   2023The Lancet103 citations Open access

   Semantic Scholar

   Save

8. Defining a severe asthma super-responder: findings from a Delphi process.

   J. Upham, C. Le Lievre, D. Jackson, M. Masoli +2 more

   2021Journal of Allergy and Clinical Immunology: In Practice102 citations Open access

   Semantic Scholar

   Save

9. Dose–response relationship for risk of non‐vertebral fracture with inhaled corticosteroids

   M. Weatherall, K. James, J. Clay, K. Perrin +3 more

   2008Clinical and Experimental Allergy84 citations

   Semantic Scholar

   Save

10. Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)

    R. Niven, D. Saralaya, R. Chaudhuri, M. Masoli +5 more

    2016BMJ Open60 citations Open access

    Semantic Scholar

    Save

11. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA

    J. Bousquet, M. Bewick, A. Cano, P. Eklund +277 more

    2016The Journal of Nutrition, Health & Aging55 citations Open access

    Semantic Scholar

    Save

12. The construction and validation of the Severe Asthma Questionnaire

    M. Hyland, Rupert C. Jones, J. Lanario, M. Masoli

    2018European Respiratory Journal49 citations Open access

    Semantic Scholar

    Save

13. Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis

    M. Masoli, M. Weatherall, Shaun Holt, P. Shirtcliffe +1 more

    2006European Respiratory Journal49 citations Open access

    Semantic Scholar

    Save

14. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

    2022The Lancet45 citations Open access

    Semantic Scholar

    Save

15. Budesonide once versus twice‐daily administration: meta‐analysis

    M. Masoli, M. Weatherall, S. Holt, R. Beasley

    2004Respirology (Carlton South. Print)38 citations

    Semantic Scholar

    Save

16. Defining a severe asthma super-responder: findings from a Delphi process

    J. Upham, C. Le Lievre, D. Jackson, M. Masoli +2 more

    202031 citations

    Semantic Scholar

    Save

17. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

    Saul N. Faust, R. Haynes, C. Jones, N. Staplin +496 more

    2024The Lancet Child & Adolescent Health28 citations Open access

    Semantic Scholar

    Save

18. Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA)

    J. Lanario, M. Hyland, A. Menzies-Gow, A. Mansur +4 more

    2020Health and Quality of Life Outcomes27 citations Open access

    Semantic Scholar

    Save

19. How patient participation was used to develop a questionnaire that is fit for purpose for assessing quality of life in severe asthma

    M. Hyland, J. Lanario, J. Pooler, M. Masoli +1 more

    2018Health and Quality of Life Outcomes27 citations Open access

    Semantic Scholar

    Save

20. Patient-centred composite scores as tools for assessment of response to biological therapy for paediatric and adult severe asthma

    E. Khaleva, C. Brightling, T. Eiwegger, A. Altraja +73 more

    2024European Respiratory Journal25 citations Open access

    Semantic Scholar

    Save

21. Tuberculin testing, BCG and tuberculosis today

    M. Masoli, M. Weatherall, Richard Beasley

    2005Thorax25 citations Open access

    Semantic Scholar

    Save

22. Metered dose inhalers: A need for dose counters

    S. Holt, Avrille Holt, M. Weatherall, M. Masoli +1 more

    2005Respirology (Carlton South. Print)24 citations

    Semantic Scholar

    Save

23. Effects of obesity on response to asthma biologic treatment: Longitudinal data from the United Kingdom Severe Asthma Registry.

    S. Gonem, C. Redmond, John Busby, Pujan H. Patel +19 more

    2025Journal of Allergy and Clinical Immunology: In Practice19 citations Open access

    Semantic Scholar

    Save

24. Fluticasone given once versus twice a day: Meta‐analysis

    M. Masoli, M. Weatherall, R. Beasley

    2005Respirology (Carlton South. Print)19 citations

    Semantic Scholar

    Save

25. Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis

    J. A. Kroes, R. Alfonso-Cristancho, A. Bansal, E. Berret +40 more

    2023ERJ Open Research16 citations Open access

    Semantic Scholar

    Save

26. The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler.

    M. Masoli, M. Weatherall, J. Ayling, Mathew Williams +1 more

    2005Respiratory Medicine16 citations Open access

    Semantic Scholar

    Save

27. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    O. A. F. J. K. M. S. H. A. Abani Abbas Abbas Abbas Abbas Abbas Abbasi Abbass, O. Abani, A. Abbas, F. Abbas +496 more

    2023The Lancet Diabetes and Endocrinology15 citations Open access

    Semantic Scholar

    Save

28. Evidence for similarity in symptoms and mechanism: The extra‐pulmonary symptoms of severe asthma and the polysymptomatic presentation of fibromyalgia

    M. Hyland, J. Lanario, Yinghui Wei, Rupert C. Jones +1 more

    2019Immunity, Inflammation and Disease14 citations Open access

    Semantic Scholar

    Save

29. The dose-response relationship of inhaled corticosteroids in asthma

    M. Masoli, S. Holt, M. Weatherall, R. Beasley

    2004Current Allergy and Asthma Reports13 citations

    Semantic Scholar

    Save

30. The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference

    M. Masoli, J. Lanario, M. Hyland, A. Menzies-Gow +7 more

    2021European Respiratory Journal12 citations Open access

    Semantic Scholar

    Save

31. The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?

    K. Eger, D. Paróczai, A. Bacon, F. Schleich +62 more

    2022ERJ Open Research11 citations Open access

    Semantic Scholar

    Save

32. Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma

    M. Hyland, J. Lanario, A. Menzies-Gow, A. Mansur +5 more

    2021Chronic Respiratory Disease11 citations Open access

    Semantic Scholar

    Save

33. Comparison of the effects of pulmonary and extra-pulmonary symptoms on health-related quality of life in patients with severe asthma.

    J. Lanario, M. Hyland, Yinghui Wei, Rupert C. Jones +1 more

    2020Respiratory Medicine11 citations Open access

    Semantic Scholar

    Save

34. The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler.

    M. Masoli, Mathew Williams, M. Weatherall, R. Beasley

    2006Respiratory Medicine11 citations Open access

    Semantic Scholar

    Save

35. Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    O. Abani, A. Abbas, F. Abbas, J. Abbas +496 more

    2025Lancet. Infectious Diseases (Print)9 citations Open access

    Semantic Scholar

    Save

36. “Life-changing”: the experience of super-responders to biologics in severe asthma

    J. Lanario, Lucy Cartwright, Rupert C. Jones, Ross Sayers +2 more

    2022BMC Pulmonary Medicine9 citations Open access

    Semantic Scholar

    Save

37. A Possible Explanation for Non-responders, Responders and Super-responders to Biologics in Severe Asthma

    M. Hyland, M. Masoli, J. Lanario, Rupert C. Jones

    2019Exploratory Research and Hypothesis in Medicine8 citations Open access

    Semantic Scholar

    Save

38. “Life-changing”- the experience of super-responders to biologics in severe asthma

    J. Lanario, Lucy Cartwright, Rupert C. Jones, Ross Sayers +2 more

    202205.02 - Monitoring airway disease6 citations

    Semantic Scholar

    Save

39. Fixed and adjustable dose asthma action plans based on combination therapy: A pilot study

    S. Holt, Simon Ryder-Lewis, M. Masoli, M. Weatherall +1 more

    2005Respirology (Carlton South. Print)6 citations

    Semantic Scholar

    Save

40. Inhaled Corticosteroid Therapy in the Management of Asthma in Adults: Leukotriene Modifiers

    M. Masoli, P. Shirtcliffe, S. Holt, M. Weatherall +1 more

    20056 citations

    Semantic Scholar

    Save

41. Pre-biologic assessment of adherence in severe asthma and association with biologic continuation: a UK Severe Asthma Registry Study

    Freda Yang, Ronald McDowell, John Busby, Anna Murphy +25 more

    2025BMJ Open Respiratory Research5 citations Open access

    Semantic Scholar

    Save

42. Impact of comorbidities on EQ-5D quality-of-life index in severe asthma

    P. Pfeffer, Thomas Brown, Rekha Chaudhuri, Shoaib Faruqi +11 more

    2024Journal of Allergy and Clinical Immunology: Global5 citations Open access

    Semantic Scholar

    Save

43. "Difficult asthma": not as easy as you think.

    M. Masoli

    2015Chest5 citations

    Semantic Scholar

    Save

44. Moving towards patient-centred outcomes: the Severe Asthma Questionnaire

    D. Davies, M. Hyland, J. Lanario, Rupert C. Jones +1 more

    2022European Respiratory Journal3 citations Open access

    Semantic Scholar

    Save

45. Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice.

    R. Beasley, James Harper, M. Masoli

    2020The Lancet Respiratory Medicine3 citations

    Semantic Scholar

    Save

46. Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

    O. A. F. J. K. M. S. H. A. Abani Abbas Abbas Abbas Abbas Abbas Abbasi Abbass, O. Abani, A. Abbas, F. Abbas +496 more

    2025EClinicalMedicine2 citations Open access

    Semantic Scholar

    Save

47. A lifestyle educational course as an adjunct to biologic administration in patients with severe asthma: A feasibility study

    J. Lanario, Drew Davies, Lucy Cartwright, M. Hyland +1 more

    2024PEC Innovation2 citations Open access

    Semantic Scholar

    Save

48. Severe Asthma Questionnaire (SAQ) and Asthma Control Questionnaire (ACQ) as Early Predictors of Biologic Response in Severe Asthma

    Drew Davies, J. Lanario, M. Hyland, M. Masoli

    2023Journal of Asthma and Allergy2 citations Open access

    Semantic Scholar

    Save

49. Patients' knowledge, perspectives and attitudes towards treatment goals and clinical remission in severe asthma

    Shi-Yuan Zhang, A. Raimondi, Olivia Fulton, V. Mcdonald +7 more

    2023Airway pharmacology and treatment2 citations

    Semantic Scholar

    Save

50. Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma

    Giulio de Felice, M. Hyland, J. Lanario, Yuri Antonacci +2 more

    2021BMC Pulmonary Medicine2 citations Open access

    Semantic Scholar

    Save